← All stocks

SOPHiA GENETICS SA

SOPH Mostly scheduled
CIK 0001840706 #2827 in the set updated 17 Sep 2026
Bought (12 mo)
$99.00K
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$4.38M
$3.16M on a plan · $1.17M straight out of an exercise
Sold at will
$44.02K
11 of 135 sales
Net
−$4.28M
+$54.98K against sales at will

By person

14 insiders · 136 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Camblong Jurgi
Executive Chairman
$2.34M (32) scheduled
−$2.34M
3,435,822
5.02%
$27.09M
+3.9%
Xu Zhenyu
Chief Scientific Officer
$725.30K (25) scheduled
−$725.30K
552,887
0.8073%
$4.36M
+2.8%
Menu Philippe
Chief Medical Officer
$442.52K (22) scheduled
−$442.52K
208,387
0.3043%
$1.64M
+19.6%
Verma Abhimanyu
Chief Technology Officer
$240.21K (8) scheduled
−$240.21K
172,171
0.2514%
$1.36M
+36.8%
Muken Ross
Chief Executive Officer
$166.22K (12) scheduled
−$166.22K
670,651
0.9792%
$5.29M
+145.6%
Valente Manuela
Chief People Officer
$149.10K (8) scheduled
−$149.10K
210,450
0.3073%
$1.66M
+37.8%
HIBBS KATHY L
Director
$140.09K (3) scheduled
−$140.09K
96,992
0.1416%
$764.72K
−0.3%
Van Well Daan
Chief Legal Officer
$116.37K (9) scheduled
−$116.37K
338,884
0.4948%
$2.67M
+29.4%
CARDOZA GEORGE
Chief Financial Officer
$99.00K (1)
$47.07K (6) scheduled
+$51.93K
309,092
0.4513%
$2.44M
+66.5%
Puylaert Kevin
Chief Sales Officer
$4.61K (10)
−$4.61K
147,948
0.2160%
$1.17M
+60.1%
Ossipow Vincent
Director
522,860
0.7635%
$4.12M
+3.9%
Cox Troy
Director
328,743
0.4800%
$2.59M
+6.4%
HIRSCH DIDIER
Director
240,220
0.3508%
$1.89M
+8.9%
Cossery Jean-Michel
Director
206,212
0.3011%
$1.63M
+10.6%
Insider
Date
Role
Action
Shares
Price
Amount
Valente Manuela
19 Aug 2026
Chief People Officer
Sold after exercise
10,000
$7.94
$79.44K
Xu Zhenyu
7 Aug 2026
Chief Scientific Officer
Sold after exercise
10,000
$7.48
$74.76K
Xu Zhenyu
7 Aug 2026
Chief Scientific Officer
Sold after exercise
7,000
$7.02
$49.15K
Xu Zhenyu
5 Aug 2026
Chief Scientific Officer
Sold after exercise
3,000
$7.00
$21.01K
Camblong Jurgi
20 Jul 2026
Executive Chairman
Sold after exercise
4,581
$6.17
$28.24K
Camblong Jurgi
20 Jul 2026
Executive Chairman
Sold after exercise
19,800
$6.32
$125.20K
Camblong Jurgi
30 Jun 2026
Executive Chairman
Sold after exercise
200
$6.30
$1.26K
Camblong Jurgi
30 Jun 2026
Executive Chairman
Sold after exercise
19,650
$6.02
$118.32K
Camblong Jurgi
30 Jun 2026
Executive Chairman
Sold after exercise
45,419
$6.14
$279.05K
Camblong Jurgi
29 Jun 2026
Executive Chairman
Sold after exercise
350
$6.00
$2.10K
Camblong Jurgi
29 Jun 2026
Executive Chairman
Sold after exercise
18,060
$5.87
$105.96K
Camblong Jurgi
26 Jun 2026
Chief Executive Officer
Sold after exercise
31,940
$5.84
$186.40K
Camblong Jurgi
26 Jun 2026
Chief Executive Officer
Sold after exercise
18,129
$5.73
$103.93K

What was left out

Form 4 filings counted 111
Amendments (4/A) skipped 9
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 111
Sales straight out of an exercise 13
Sales at will 11
Transactions with no price 0
Shares from compensation/vesting 1,727,859
History held since 20 Mar 2026